Results 261 to 270 of about 292,142 (337)

Cardiopulmonary arrest following extradural analgesia and suspected secondary sympathetic blockade in a critically ill dog

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract An 8‐year‐old, male, entire Cocker Spaniel presented to the Queen Mother Hospital for Animals for treatment of an iatrogenic septic uroabdomen secondary to traumatic urinary catheterisation. After initial stabilisation, it underwent diagnostic imaging and definitive surgical correction comprising a cystotomy and bladder reconstruction.
Joe Simon, Manuel Enrique Herrera‐Linares, Hannah Louise Matson, Cristina Bianchi   +3 more
wiley   +1 more source

Longitudinal Study of Plasma NFL and GFAP as Biomarkers of Alcohol Withdrawal–Associated Brain Injury

Addiction Biology, Volume 31, Issue 5, May 2026.
Brain injury could occur within the first days of alcohol withdrawal, especially in patients with severe pharmacological dependence. Plasma NFL and GFAP are promising biomarkers of alcohol withdrawal‐related brain pathology. ABSTRACT Plasma neurofilament light chain (NFL), glial fibrillary acidic protein (GFAP), tau protein and ubiquitin carboxy ...
Virgile Clergue‐Duval, Frank Questel, Alexandra Dereux, Elodie Bouaziz‐Amar, Julien Azuar, Romain Icick, Dorian Rollet, Vanessa Bloch, Jérôme Jeanblanc, Cynthia Marie‐Claire, Jean‐Louis Laplanche, Frank Bellivier, Claire Paquet, Mickael Naassila, Florence Vorspan   +14 more
wiley   +1 more source

Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada. [PDF]

Harm Reduct J
Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R.   +5 more
europepmc   +1 more source

A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory

Addiction, Volume 121, Issue 5, Page 1272-1289, May 2026.
Abstract Background and aims Harm reduction interventions aim to reduce negative consequences of drug use. We aimed to estimate the cost, health impact and economic benefits of current, expanded and new harm reduction interventions for people who use drugs in the Australian Capital Territory.
Anna L. Bowring, Tom Tidhar, Anna Olsen, Christopher Bailie, Kelvin Burke, Rowan Martin‐Hughes, Helen Keane, Paul Dietze, Nick Scott   +8 more
wiley   +1 more source

Desirable treatment or a problematic drug scene? - An interview study of patients' and professionals' views on the risks and benefits of liberalized opioid agonist treatment. [PDF]

Harm Reduct J
Nordgren J, Richert T.
europepmc   +1 more source

The association of methadone use with physical function and frailty among persons who inject drugs

Addiction, Volume 121, Issue 5, Page 1217-1226, May 2026.
Abstract Background and Aims Persons who inject drugs (PWID) experience a high burden of early‐onset frailty, primarily due to multifactorial causes such as infections (human immunodeficiency virus [HIV], hepatitis C virus [HCV]), substance use, and polypharmacy.
Grace L. Kulik, Hsing‐Yu Hsu, Jacqueline Rudolph, Yutong Jiang, Kristine M. Erlandson, Damani A. Piggott, Shruti Mehta, Jeremy D. Walston, Gregory Kirk, Todd T. Brown, Jing Sun   +10 more
wiley   +1 more source

Examining Differences Among Opioid Agonist Treatment Clients in Regional and Metropolitan Settings of New South Wales, Australia. [PDF]

Aust J Rural Health
Winter DT, Monds LA, Lintzeris N, Haber PS, Day CA.   +4 more
europepmc   +1 more source

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Addiction, Volume 121, Issue 5, Page 1083-1099, May 2026.
Abstract Background and aims There has been limited evidence synthesis examining the treatment of buprenorphine precipitated opioid withdrawal (BPOW). We aimed to conduct the first systematic review to assess the clinical utility of any pharmacological intervention in the management of BPOW.
Emmert Roberts, Nicola Kalk, John Strang
wiley   +1 more source

Comparative effectiveness of maintenance doses of opioid agonist treatment among individuals with opioid use disorder: a target trial emulation protocol using a population-based observational study. [PDF]

BMJ Open
Zanette M, Min JE, Homayra F, Bach P, Socías ME, Bruneau J, Korthuis PT, Karim E, Seaman S, Bozinoff N, Kennedy MC, Nosyk B.   +11 more
europepmc   +1 more source

Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms

The American Journal on Addictions, Volume 35, Issue 3, Page 412-421, May 2026.
Abstract Background and Objectives Attention‐deficit/hyperactivity disorder (ADHD) is recognized as a condition that can persist into adulthood, often with psychiatric comorbidities that worsen the overall prognosis. ADHD has been associated with substance use disorders (SUDs), especially through symptoms like hyperactivity and impulsivity, while the ...
Maddalena Cesco, Marco Garzitto, Livia Pischiutta, Tiziana Lombardelli, Enrico Moratti, Giuliano Zamparutti, Matteo Balestrieri, Umberto Albert, Marco Colizzi   +8 more
wiley   +1 more source